S-glutathionylation: Indicator of cell stress and regulator of the unfolded protein response

Molecular Interventions

Volumn 7, Issue 6, 2008, Pages 313-324

  Townsend, Danyelle M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS SIGNAL REGULATING KINASE 1; C EBP HOMOLOGOUS PROTEIN; CISPLATIN; CYSTEINE PROTEINASE; DOXORUBICIN; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NOV 002; PANCREATIC ENDOPLASMIC RETICULUM KINASE; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN DISULFIDE ISOMERASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

CELL STRESS; CHEMICAL REACTION; DIMERIZATION; ENDOPLASMIC RETICULUM; HEMATOLOGIC MALIGNANCY; HUMAN; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; S GLUTATHIONYLATION; SIGNAL TRANSDUCTION; SOLID TUMOR;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CYSTEINE; ENDOPLASMIC RETICULUM; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN DISULFIDE-ISOMERASE; PROTEIN FOLDING; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 38349049487     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.7.6.7     Document Type: Review

References (94)

1. Beer, S.M., Taylor, E.R., Brown, S.E., Dahm, C.C., Costa, N.J., Runswick, M.J., and Murphy, M.P. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: Implications for mitochondrial redox regulation and antioxidant DEFENSE. J. Biol. Chem. 279, 47939-47951 (2004).
2. Shelton, M.D., Chock, P.B., and Mieyal, J.J. Glutaredoxin: Role in reversible protein S-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid. Redox. Signal. 7, 348-366 (2005).
3. Findlay, V.J., Townsend, D.M., Saavedra, J.E., Buzard, G.S., Citro, M.L., Keefer, L.K., Ji, X., and Tew, K.D. Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Mol. Pharmacol. 65, 1070-1079 (2004).
4. Tew, K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54, 4313-4320 (1994).
5. Adler, V., Yin, Z., Fuchs, S.Y. et al. Regulation of JNK signaling by GSTp. EMBO J. 18, 1321-1334 (1999).
6. Wang, T., Arifoglu, P., Ronai, Z., and Tew, K.D. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J. Biol. Chem. 276, 20999-21003 (2001). This work, along with reference (5), establishes that pi GST is more than a Phase II detoxification enzyme. The non-catalytic properties of pi GST encompass kinase regulation and mediation of S-glutathionylation reactions. As such, GST is a regulator of multiple signaling pathways that govern survival and apoptotic pathways.
7. Yin, Z., Ivanov, V.N., Habelha, H., Tew, K., and Ronai, Z. Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res. 60, 4053-4057 (2000).
8. Cross, J.V. and Templeton, D.J. Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem J. 381, 675-683 (2004).
9. Klatt, P. and Lamas, S. c-Jun regulation by S-glutathionylation. Methods Enzymol. 348, 157-174 (2002).
10. Townsend, D.M., Keefer, L.K., Saavedra, J.E., Pazoles, C.J., and Tew, K.D. (Unpublished results.)
11. Romero, L., Andrews, K., Ng, L., O'Rourke, K., Maslen, A., and Kirby, G. Human GSTA1-1 reduces c-Jun N-terminal kinase signaling and apoptosis in Caco-2 cells. Biochem. J. 400, 135-141 (2006).
12. Manevich, Y., Feinstein, S.I., and Fisher, A.B. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc. Natl. Acad. Sci. USA 101, 3780-3785 (2004).
13. Ralat, L.A., Manevich, Y., Fisher, A.B., and Colman, R.F. Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes. Biochemistry 45, 360-372 (2006).
14. Kim, Y.J., Lee, W.S., Ip, C., Chae, H.Z., Park, E.M., and Park, Y.M. Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. Cancer Res. 66, 7136-7142 (2006).
15. Wu, Y., Fan, Y., Xue, B., Luo, L., Shen, J., Zhang, S., Jiang, Y., and Yin, Z. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25, 5787-5800 (2006).
16. Townsend, D.M. (Unpublished results.)
17. Fiaschi, T., Cozzi, G., Raugei, G., Formigli, L., Ramponi, G., and Chiarugi, P. Redox regulation of beta-actin during integrin-mediated cell adhesion. J. Biol. Chem. 281, 22983-22991 (2006).
18. Chen, F.C. and Ogut, O. Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin. Am. J. Physiol. Cell Physiol. 290, C719-727 (2006).
19. Hartl, F.U. and Hayer-Hartl, M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295, 1852-1858 (2002).
20. Tu, B.P. and Weissman, J.S. Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell Biol. 164, 341-346 (2004).
21. Feldman, D.E., Chauhan, V. and Koong, A.C. The unfolded protein response: A novel component of the hypoxic stress response in tumors. Mol. Cancer Res. 3, 597-605 (2005). ER stress is a molecular signature of tumor hypoxia. Proteins critical to UPR-induced apoptosis are novel targets for chemotherapeutic strategies.
22. Evans, S.M. and Koch, C.J. Prognostic significance of tumor oxygenation in humans. Cancer Lett. 195, 1-16 (2003).
23. Brewer, J.W. and Diehl, J.A. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc. Natl. Acad. Sci. USA 97, 12625-12630 (2000).
24. Rao, R.V. and Bredesen, D.E. Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr. Opin. Cell Biol. 16, 653-662 (2004).
25. Wang, X.Z. and Ron, D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 272, 1347-1349 (1996).
26. Hetz, C., Bernasconi, P., Fisher, J. et al. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 312, 572-576 (2006).
27. Zong, W.X., Li, C., Hatzivassiliou, G., Lindsten, T., Yu, Q.C., Yuan, J., and Thompson, C.B. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J. Cell Biol. 162, 59-69 (2003).
28. Scorrano, L., Oakes, S.A., Opferman, J.T., Cheng, E.H., Sorcinelli, M.D., Pozzan, T., and Korsmeyer, S.J. BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis. Science 300, 135-139 (2003).
29. Pihlajaniemi, T., Helaakoski, T., Tasanen, K., Myllylä, R., Huhtala, M.L., Koivu, J., and Kivirikko, K.I. Molecular cloning of the beta-subunit of human prolyl 4-hydroxylase. This subunit and protein disulphide isomerase are products of the same gene. EMBO J. 6, 643-6649 (1987).
30. Ferrari, D.M. and Soling, H.D. The protein disulphide-isomerase family: Unravelling a string of folds. Biochem. J. 339, 1-10 (1999).
31. Tian, G., Xiang, S., Noiva, R., Lennarz, W.J., and Schindelin, H. The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites. Cell 124, 61-73 (2006).
32. Farjanel, J., Perier, C., Szymanovicz, G., and Frey, J. Simultaneous characterizations of 3-prolylhydroxylase and 4-prolylhydroxylase activities by ion exchange chromatography. Biochimie 62, 195-199 (1980).
33. Pirneskoski, A., Ruddock, L.W., Klappa, P., Freedman, R.B., Kivirikko, K.I., and Koivunen, P. Domains b' and a' of protein disulfide isomerase fulfill the minimum requirement for function as a subunit of prolyl 4-hydroxylase. The N-terminal domains a and b enhances this function and can be substituted in part by those of ERp57. J. Biol. Chem. 276, 11287-11293 (2001).
34. Landel, C.C., Kushner, P.J. and Greene, G.L. The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol. Endocrinol. 8, 1407-1419 (1994).
35. Schultz-Norton, J.R., McDonald, W.H., Yates, J.R., and Nardulli A.M. Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor alpha structure and function. Mol. Endocrinol. 20, 1982-1995 (2006).
36. Uehara, T., Nakamura, T., Yao, D., Shi, Z.Q., Gu, Z., Ma, Y., Masliah, E., Nomura, Y., and Lipton, S.A. S-nitrosylated protein disulphide isomerase links protein misfolding to neurodegeneration. Nature 441, 513-517 (2006). Nitrosylation of PDI in the brains of patients with Parkinson's and Alzheimer's disease underscores the importance of this protein to normal cellular function.
37. Townsend, D.M., Findlay, V.J., Fazilev. F., Ogle. M., Fraser. J., Saavedra, J.E., Ji, X., Keefer, L.K., and Tew, K.D. A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins. Mol. Pharmacol. 69, 501-508 (2006). Exploitation of PDI through drug-induced S-glutathionylation is a unique strategy to target cancer cells.
38. Chen, C.Y., Jia, J.H., Zhang, M.X., Meng, Y.S., Kong, D.X., Pan, X.L., and Yu, XP. Proteomic analysis on multi-drug resistant cells HL-60/DOX of acute myeloblastic leukemia. Chin. J. Physiol. 48,. 115-120 (2005).
39. Persson, S., Rosenquist, M., Knoblach, B., Khosravi-Far, R., Sommarin, M., and Michalak, M. Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family. Mol. Phylogenet. Evol. 36, 734-740 (2005).
40. Shin, B.K., Wang, H., Yim, A.M.et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 278, 7607-7616 (2003).
41. Chen, S.T., Pan, T.L., Tsai, Y.C., and Huang, C. M. Proteomics reveals protein profile changes in doxorubicin-treated MCF-7 human breast cancer cells. Cancer Lett. 181, 95-107 (2002).
42. Bini, L., Magi, B., Marzocchi, B. et al. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18, 2832-2841 (1997).
43. Moncada, S. Nitric oxide in the vasculature: Physiology and pathophysiology. Ann. NY Acad. Sci. 811, 60-67 (1997).
44. Ilic, T.V., Jovanovic, M., Jovicic, A., and Tomovic, M. Oxidative stress indicators are elevated in de novo Parkinson's disease patients. Funct. Neurol. 14, 141-147 (1999).
45. Tieu, K., Ischiropoulos, H., and Przedborski, S. Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 55, 329-335 (2003).
46. Townsend, D. and Tew, K. Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am. J. Pharmacogenomics 3, 157-172 (2003).
47. Cui, S., Reichner, J.S., Mateo, R.B., and Albina, J.E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54, 2462-2467 (1994).
48. Saavedra, J.E., Billiar, T.R., Williams, D.L., Kim, Y.M., Watkins, S.C., and Keefer, LK. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J. Med. Chem. 40, 1947-1954 (1997).
49. O'Brien, M., Kruh, G.D. and Tew, K.D. The influence of coordinate over-expression of glutathione phase II detoxification gene products on drug resistance. J. Pharmacol. Exp. Ther. 294, 480-487 (2000).
50. Townsend, D.M. (Unpublished results.)
51. Findlay, V.J., Townsend, D.M., Morris, T.E., Fraser, J.P., He, L., and Tew, K.D. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res. 66, 6800-6806 (2006).
52. Asmis, R., Wang, Y., Xu, L., Kisgati, M., Begley, J.G., and Mieyal, J.J. A novel thiol oxidation-based mechanism for adriamycin-induced cell injury in human macrophages. FASEB J. 19, 1866-1868 (2005).
53. Tew, K.D. and Ali-Osman, F. Redox pathways in cancer drug discovery. Curr. Opin. Pharmacol. 7, 353-354 (2007).
54. Townsend, D.M., et al. NOV-002, a glutathione disulfide mimetic,as a modulator of cellular redox balance. Cancer Res. (in press).
55. Pompella, A., Corti, A., Paolicchi, A. Giommarelli, C., and Zunino, F. γ-Glutamyltransferase, redox regulation and cancer drug resistance. Curr. Opin. Pharmacol. 7, 360-366 (2007).
56. Wang, J., Boja, E.S., Tan, W., Tekle, E., Fales, H.M., English, S., Mieyal, J.J., and Chock, P.B. Reversible glutathionylation regulates actin polymerization in A431 cells. J. Biol. Chem. 276, 47763-47766 (2001).
57. Rossi, R., Giustarini, D., Milzani, A., and Dalle-Donne, I. Membrane skeletal protein S-glutathionylation and hemolysis in human red blood cells. Blood Cells Mol. Dis. 37, 180-187 (2006).
58. Landino, L.M., Moynihan, K.L., Todd, J.V., Kennett, K.L. Modulation of the redox state of tubulin by the glutathione/glutaredoxin reductase system. Biochem. Biophys. Res. Commun. 314, 555-560 (2004).
59. Fratelli, M., Demol, H., Puype, M. et al. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc. Natl. Acad. Sci. USA 99, 3505-3510 (2002).
60. Cotgreave, I.A., Gerdes, R., Schuppe-Koistinen, I., and Lind, C. S-glutathionylation of glyceraldehyde-3-phosphate dehydrogenase: role of thiol oxidation and catalysis by glutaredoxin. Methods Enzymol. 348, 175-182 (2002).
61. Nulton-Persson, A.C. Starke, D.W., Mieyal, J.J., and Sweda, L.I. Reversible inactivation of alpha-ketoglutarate dehydrogenase in response to alterations in the mitochondrial glutathione status. Biochemistry 42, 4235-4242 (2003).
62. Taylor, E.R., Hurrell, F., Shannon, R.J., Lin, T.K., Hirst, J., and Murphy, M.P. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J. Biol. Chem. 278, 19603-19610 (2003).
63. Kil, I.S. and Park, J.W. Regulation of mitochondrial NADP+-dependent isocitrate dehydrogenase activity by glutathionylation. J. Biol. Chem. 280, 10846-10854 (2005).
64. Mohr, S., Hallak, H., de Boitte, A., Lapetina, E.G., and Brüne, B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 274, 9427-94230 (1999).
65. Chen, C.L., Zhang, L., Yeh, A., Chen, C.A., Green-Church, K.B., Zweier, J.L., and Chen Y.R. Site-specific S-glutathiolation of mitochondrial NADH ubiquinone reductase. Biochemistry 46, 5754-5765 (2007).
66. Klatt, P., Pineda Molena, E., Perez-Sala, D., and Lamas, S. Novel application of S-nitrosoglutathione-Sepharose to identify proteins that are potential targets for S-nitrosoglutathione-induced mixed-disulphide formation. Biochem J. 349, 567-578 (2000).
67. Cotton, N.J., Stoddard, B. and Parson, W.W. Oxidative inhibition of human soluble catechol-O-methyltransferase. J. Biol. Chem. 279, 23710-23718 (2004).
68. Odin, J.A., Huebert, R.C., Casciola-Rosen, L., LaRusso, N.F., and Rosen, A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J. Clin. Invest. 108, 223-232 (2001).
69. Yu, C.X., Li, S., and Whorton, A.R. Redox regulation of PTEN by S-nitrosothiols. Mol. Pharmacol. 68, 847-854 (2005).
70. Reynaert, N.L., van der Vilet, A., Guala, A.S. et al. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc. Natl. Acad. Sci. USA 103, 13086-13091 (2006).
71. Shelton, M.D., Kern, T.S., and Mieyal, J.J. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: Model of diabetic retinopathy. J. Biol. Chem. 282, 12467-12474 (2007).
72. Ward, N.E., Stewart, J.R., Ioannides, C.G., and O'Brian, C.A. Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation. Biochemistry 39, 10319-10329 (2000).
73. Burgoyne, J.R., Madhani, M., Cuello, F., Charles, R.L., Brennan, J.P., Schröder, E., Browning, D.D., and Eaton, P. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317, 1393-1397 (2007).
74. Humphries, K.M., Deal, M.S. and Taylor, S.S. Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification. J. Biol. Chem. 280, 2750-2758 (2005).
75. Leonberg, A.K. and Chai, Y.C.The functional role of cysteine residues for c-Abl kinase activity. Mol. Cell. Biochem. 304, 207-212 (2007).
76. Velu, C.S., Niture, S.K., Doneanu, C.E., Pattabiraman, N., and Srivenugopal, K.S. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46, 7765-7780 (2007).
77. Adachi, T., Pinentel, D.R., Heilbeck, T., Hou, X., Lee, Y.J., Jiang, B. Ido, Y., and Cohen, R.A. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 279, 29857-29862 (2004).
78. Goch, G., Vdovenko, S., Kozlowska, H., and Bierzynski, A. Affinity of S100A1 protein for calcium increases dramatically upon glutathionylation. FEBS J. 272, 2557-2565 (2005).
79. Adachi, T., Weisbrod, R.M., Pimental, D.R., Ying, J., Sharov, V.S., Schoneich, C., and Cohen, R.A. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat. Med. 10, 1200-1207 (2004).
80. Hidalgo, C., Sanchez, G., Barrientos, G., and Aracena-Parks, P. A transverse tubule NADPH oxidase activity stimulates calcium release from isolated triads via ryanodine receptor type 1 S-glutathionylation. J. Biol. Chem. 281, 26473-26482 (2006).
81. Wang, W., Oliva, C., Li, G., Holmgren, A., Lillig, C.H., and Kirk, K.L. Reversible silencing of CFTR chloride channels by glutathionylation. J. Gen. Physiol. 125, 127-141 (2005).
82. Demasi, M., Shringarpure, R., and Davies, K.J. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch. Biochem. Biophys. 389, 254-263 (2001).
83. Haendeler, J. Thioredoxin-1 and posttranslational modifications. Antioxid. Redox Signal. 8, 1723-1728 (2006).
84. Noguera-Mazon, V., Lemoine, J., Walker, O., Rouhier, N. Salvador, A., Jacquot, J.P., Lancelin, J.M., and Krimm, I. Glutathionylation induces the dissociation of 1-Cys D-peroxiredoxin non-covalent homodimer. J. Biol. Chem. 281, 31736-31742 (2006).
85. Pastore, A., Tozzi, G., Gaeta, L.M. et al. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J. Biol. Chem. 278, 42588-42595 (2003).
86. Toth, A., Nickson, P., Mandl, A., Bannister, M.L., Toth, K., and Erhardt, P. Endoplasmic reticulum stress as a novel therapeutic target in heart diseases. Cardiovasc. Hematol. Disord. Drug Targets 7, 205-218 (2007).
87. Dinoto, L., Deture, M.A., and Purich, D.L. Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein. Microsc. Res. Tech. 67, 156-163 (2005).
88. Unterberger, U., Höftberger, R., Gelpi, E., Flicker, H., Budka, H., and Voigtländer, T. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J. Neuropathol. Exp. Neurol. 65, 348-357 (2006).
89. Sampathkumar, R., Balasubramanyam, M., Sudarslal, S., Rema, M., Mohan, V., and Balaram, P. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy. Clin. Biochem. 38, 892-899 (2005).
90. Allen, J.R., Nguyen, L.X., Sargent, K.E., Lipson, K.L., Hackett, A., and Urano, F. High ER stress in beta-cells stimulates intracellular degradation of misfolded insulin. Biochem. Biophys. Res. Commun. 324, 166-170 (2004).
91. Nanua, S., Sajjan, U., Keshavjee, S., and Hershenson, M.B. Absence of typical unfolded protein response in primary cultured cystic fibrosis airway epithelial cells. Biochem. Biophys. Res. Commun. 343, 135-143 (2006).
92. Craghill, J., Cronshaw, A.D. and Harding, J.J. The identification of a reaction site of glutathione mixed-disulphide formation on gammaS-crystallin in human lens. Biochem J. 379, 595-600 (2004).
93. Shinohara, T., Ikesugi, K., and Mulhern, M.L. Cataracts: Role of the unfolded protein response. Med. Hypotheses 66, 365-370 (2006).
94. Sevier, C.S., Qu, H., Heldman, N., Gross, E., Fass, D., and Kaiser, C.A. Modulation of cellular disulfide bond formation and the ER redox environment by feedback regulation of ERO1. Cell 129, 333-344 (2007).